Outset Medical, Inc. (OM)
NASDAQ: OM · Real-Time Price · USD
4.390
-0.330 (-6.99%)
At close: Dec 5, 2025, 4:00 PM EST
4.450
+0.060 (1.37%)
After-hours: Dec 5, 2025, 7:46 PM EST
Outset Medical Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Outset Medical stock have an average target of 16, with a low estimate of 14 and a high estimate of 17. The average target predicts an increase of 264.46% from the current stock price of 4.39.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Outset Medical stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 1 | 1 | 1 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $17 → $14 | Strong Buy | Maintains | $17 → $14 | +218.91% | Nov 11, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $22 → $17 | Hold | Maintains | $22 → $17 | +287.24% | Nov 11, 2025 |
| BTIG | BTIG | Strong Buy Maintains $39 → $17 | Strong Buy | Maintains | $39 → $17 | +287.24% | Nov 11, 2025 |
| RBC Capital | RBC Capital | Hold Reiterates $22 | Hold | Reiterates | $22 | +401.14% | Aug 19, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $21 → $22 | Hold | Maintains | $21 → $22 | +401.14% | Aug 7, 2025 |
Financial Forecast
Revenue This Year
120.25M
from 113.69M
Increased by 5.77%
Revenue Next Year
131.22M
from 120.25M
Increased by 9.12%
EPS This Year
-4.59
from -36.95
EPS Next Year
-2.74
from -4.59
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 123.4M | 136.5M | ||||
| Avg | 120.3M | 131.2M | ||||
| Low | 113.2M | 121.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 8.5% | 13.5% | ||||
| Avg | 5.8% | 9.1% | ||||
| Low | -0.4% | 1.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -4.05 | -2.12 | ||||
| Avg | -4.59 | -2.74 | ||||
| Low | -5.34 | -3.13 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.